| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/01/2010 | US20100166772 ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n |
| 07/01/2010 | US20100166769 High-yield Transgenic Mammalian Expression System for Generating Virus-like Particles |
| 07/01/2010 | US20100166767 Engineered anti-il-23r antibodies |
| 07/01/2010 | US20100166766 Engineered anti-tslp antibody |
| 07/01/2010 | US20100166763 Method for determining the immunogenicity of an antigen |
| 07/01/2010 | US20100166759 Metallothionein-Derived Peptide Fragments |
| 07/01/2010 | US20100166755 Anti-egfr antibodies |
| 07/01/2010 | US20100166753 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/2010 | US20100166751 Cancer therapy using whole glucan particles and antibodies |
| 07/01/2010 | US20100166749 Polypeptide variants with altered effector function |
| 07/01/2010 | US20100166748 C5 Antigens and Uses Thereof |
| 07/01/2010 | US20100166745 Transferrin receptor antibodies |
| 07/01/2010 | US20100166741 Altered br-3 binding polypeptides |
| 07/01/2010 | US20100166738 Compositions and methods for wt1 specific immunotherapy |
| 07/01/2010 | US20100166733 Mcp-1 splice variants and methods of using same |
| 07/01/2010 | US20100166732 Small streptococcus pyogenes antigens and their use |
| 07/01/2010 | US20100166731 Methods and Compositions for Treating Cancer |
| 07/01/2010 | US20100166728 Novel Highly Functional Enzyme Having Modified Substrate-Specificity |
| 07/01/2010 | US20100166726 Compositions for improving cellular uptake of a chemotherapeutic agent in a cell exhibiting mucin deregulation |
| 07/01/2010 | US20100166724 Uses of thioredoxin |
| 07/01/2010 | US20100166723 Genes encoding nematode toxins |
| 07/01/2010 | US20100166720 Generation of neuronal cells from pluripotent stem cells |
| 07/01/2010 | US20100166719 Hair growth method |
| 07/01/2010 | US20100166718 Large scale pancreatic islet purification |
| 07/01/2010 | US20100166716 Colony-forming unit cell of human chorion and method to obtain and use thereof |
| 07/01/2010 | US20100166714 Cardiovascular stem cells, methods for stem cell isolation, and uses thereof |
| 07/01/2010 | US20100166713 Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc) |
| 07/01/2010 | US20100166712 Bone marrow-derived mesenchymal stem cells as a source of neural progenitors |
| 07/01/2010 | US20100166710 Compositions and Methods for Inducing Neuronal Differentiation |
| 07/01/2010 | US20100166707 Extracellular matrix/metastasis modifier genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor |
| 07/01/2010 | US20100166705 Culturing circular ssDNA viruses for the production of vaccines |
| 07/01/2010 | US20100166658 Monkey homolog of human oncostatin m |
| 07/01/2010 | US20100166657 USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER |
| 07/01/2010 | US20100166652 Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody |
| 07/01/2010 | CA2748357A1 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same |
| 07/01/2010 | CA2748267A1 Large scale pancreatic islet purification |
| 07/01/2010 | CA2746892A1 Tor-interacting proteins (tips) and genes therefor |
| 07/01/2010 | CA2746112A1 Apparatus and method for the preservation of pancreatic tissue and islet cells for transplantation |
| 06/30/2010 | EP2202315A1 Modified vaccinia ankara virus variant |
| 06/30/2010 | EP2202312A2 DNA polymerases having improved labelled nucleotide incorporation properties |
| 06/30/2010 | EP2202311A2 Use of AHAS mutant genes as selection marker in potato transformation |
| 06/30/2010 | EP2202309A1 Efficient method for nuclear reprogramming |
| 06/30/2010 | EP2202307A1 Method for production of antibody |
| 06/30/2010 | EP2202304A1 Modified creatinine amidohydrolase |
| 06/30/2010 | EP2202303A1 Novel glucose dehydrogenase |
| 06/30/2010 | EP2202296A1 Process and support structure for the cultivation of living cells |
| 06/30/2010 | EP2202295A1 Method for efficient production of monocyte-derived multipotent cell (momc) |
| 06/30/2010 | EP2202245A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 06/30/2010 | EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform |
| 06/30/2010 | EP2201116A1 Means and methods for shrna mediated conditional knockdown of genes |
| 06/30/2010 | EP2201105A1 Use of the opposite cell differentiation program (ocdp) for the treatment of degenerated organs in the pathological state |
| 06/30/2010 | EP2201104A1 Methods for increasing definitive endoderm production |
| 06/30/2010 | EP2201103A2 Treatment of tumours using t lymphocyte preparations |
| 06/30/2010 | EP2201102A1 Method for coral tissue cultivation and propagation |
| 06/30/2010 | EP2201101A1 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 06/30/2010 | EP2201100A1 Enhancing the t-cells stimulatory capacity of human antigen presenting cells and their use in vaccination |
| 06/30/2010 | EP2201099A1 Method for chondrocyte expansion with phenotype retention |
| 06/30/2010 | EP2200671A1 Method for preparing porous scaffold for tissue engineering |
| 06/30/2010 | EP2200621A1 Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| 06/30/2010 | EP1721985B1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 06/30/2010 | EP1623019B1 Restricted glucose feed for animal cell culture |
| 06/30/2010 | EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction |
| 06/30/2010 | EP1399183B1 Chimeric alphavirus replicon particles |
| 06/30/2010 | EP1379625B1 Cd4+cd25+ regulatory t cells from human blood |
| 06/30/2010 | EP1036164B1 Chemokine alpha-5 |
| 06/30/2010 | CN1965075B Method of cell transdifferentiation |
| 06/30/2010 | CN1944648B Rice Cyp2 gene for increasing plant salt tolerance |
| 06/30/2010 | CN1821407B High efficiency stable expression system of transgene tomato |
| 06/30/2010 | CN101765657A Method for isolating and culturing adult stem cells derived from human amniotic epithelium |
| 06/30/2010 | CN101760452A Heterozygous cell line of embryonic stem cell and tumour cell and construction method thereof |
| 06/30/2010 | CN101760451A Preservation method of fertilized eggs and embryos of sargassum fusiforme |
| 06/30/2010 | CN101760450A Albumin/keratin double expression mice embryonic stem cell system and establishing method thereof |
| 06/30/2010 | CN101760449A Method for inducing and acclimating epidermal stem cells into muscle cells |
| 06/30/2010 | CN101760448A Method for inducing and acclimating epidermal stem cells into functional cells |
| 06/30/2010 | CN101760447A Method for inducing and acclimating epidermal stem cells into nerve cells |
| 06/30/2010 | CN101760446A Method for preparing monocyte type stem cell and application |
| 06/30/2010 | CN101760445A Method for amplifying autologous bone marrow mesenchymal stem cells |
| 06/30/2010 | CN101760444A Screening culture method for sheep oocytes in vitro |
| 06/30/2010 | CN101760443A Method for constructing photo-sensitive inductivity multifunctional stem cell graft |
| 06/30/2010 | CN101760442A Serum-free medium for MDCK cell large-scale adherent culture and single-cell suspension culture |
| 06/30/2010 | CN101759798A Marker membrane protein for purifying and enriching intradermal multipotentiality cells |
| 06/30/2010 | CN101759781A Protein adhered to surface layers of bacteria and application thereof |
| 06/30/2010 | CN101412990B Leymus chinensis fructan hydrolases, and encoding genes and use thereof |
| 06/30/2010 | CN101103701B Curcuma wenyujin detoxicating and quick reproduction method |
| 06/30/2010 | CN101070535B Method for inducing tobacco nicotine conversion in advance and use thereof |
| 06/30/2010 | CN101011035B Seashore paspalum young spike isolated culture strain-reproducing technique |
| 06/30/2010 | CN100999719B Induction of adventitious bud and body cell embryo of north American red fir leave |
| 06/29/2010 | US7745706 Maize variety PHP5D |
| 06/29/2010 | US7745705 Maize variety PHW0V |
| 06/29/2010 | US7745694 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 06/29/2010 | US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 06/29/2010 | US7745601 Nucleic acids encoding T2R, a novel family of taste receptors |
| 06/29/2010 | US7745592 Expression vector comprising cumate-inducible regulatory switch for use in gene transfer; TATA elements; bioassays; genomics and gene therapy; trangenic animals; host cells |
| 06/29/2010 | US7745581 T-bet compositions and methods of use thereof |
| 06/29/2010 | US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 06/29/2010 | US7745411 Treating anemia as a result of renal failure, AIDS, cancer, organ or bone marrow transplant, chemotherapy or radiotherapy using a peptide of given sequence, comprising angiotensin analogs |
| 06/29/2010 | US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 06/29/2010 | US7745399 Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof |
| 06/29/2010 | US7745225 determining extracellular matrix protein of the dermal tissue, obtaining fibroblasts derived from the dermal tissue, determining potential of fibroblasts to synthesize an extracellular matrix protein, determining the DNA content of the fibroblasts, assessing kinetics of fibroblast outgrowth |
| 06/29/2010 | US7745217 Graft prosthesis devices containing renal capsule collagen |